Longitudinal MR Spectroscopic Imaging of Pediatric Diffuse Pontine Tumors to Assess Tumor Aggression and Progression

References

1. ↵
   Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 1998;40:265–71

   CrossRefPubMedWeb of Science
2. ↵
   Mandell LR, Kadota R, Freeman C, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 1999;43:959–64

   CrossRefPubMedWeb of Science
3. ↵
   Krieger MD, Bluml S, McComb JG. Magnetic resonance spectroscopy of atypical diffuse pontine masses. Neurosurg Focus 2003;15:1–4
4. ↵
   Moore GJ. Proton magnetic resonance spectroscopy in pediatric neuroradiology. Pediatr Radiol 1998;28:805–14

   CrossRefPubMedWeb of Science
5. Norfray JF, Tomita T, Byrd SE, et al. Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. AJR Am J Roentgenol 1999;173:119–25

   PubMed
6. Taylor JS, Ogg RJ, Langston JW. Proton MR spectroscopy of pediatric brain tumors. Pediatr Radiol 1998;8:753–79
7. ↵
   Cecil KM, Jones BV. Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001;12:435–52

   CrossRefPubMed
8. ↵
   Motoyama Y, Ogi S, Nabeshima S. Pontine glioblastoma multiforme initially presenting with leptomeningeal gliomatosis. Neurol Med Chir (Tokyo) 2002;42:309–13

   PubMed
9. ↵
   Wang ZJ, Zimmerman RA. Proton MR spectroscopy of pediatric brain metabolic disorders. Neuroimaging Clin N Am 1998;8:781–807

   PubMed